Active Ingredient(s):Insulin Glargine FDA Approved: * June 11, 2020 Pharm Company: *MYLAN PHARMS INC Category:Diabetes
Insulin glargine [GLAR geen], sold under the brand name Lantus among others, is a long-acting insulin, used in the management of type I and type II diabetes. It is typically the recommended long acting insulin in the United Kingdom.[contradictory] It is used once a day as an injection just under the skin. Effects generally begin an hour after use.
Common side effects include low blood sugar, problems a...
* May have multiple approval dates, manufacturers, or labelers.